Semnur Pharmaceuticals, Inc. (SMNRW) Operating cash flow 2022–2025
Semnur Pharmaceuticals, Inc. (SMNRW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$5.9MFY2025 · since FY2022: -$426,095 → -$5.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.9M | -20.0% |
| FY2024 | -$4.9M | -672.9% |
| FY2023 | -$632,783 | -48.5% |
| FY2022 | -$426,095 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SMNRW financial trends
SMNRW RevenueSMNRW Net incomeSMNRW Net marginSMNRW Gross profitSMNRW Gross marginSMNRW Operating incomeSMNRW Operating marginSMNRW Free cash flowSMNRW Capital expendituresSMNRW Return on equitySMNRW Stock buybacksSMNRW Dividends paidSMNRW Total assetsSMNRW Total liabilitiesSMNRW Shareholders’ equitySMNRW overview →